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February 10, 2009:526–9ndividuals and defy reasonable adjustment, and BMI use in this
opulation becomes highly questionable.
The “central versus total fat” controversies do not seem firmly
ased, as BMI is not a trustworthy measure of total body fat, and
here is only limited evidence that WC represents some vaguely
efined central “fat compartment.” WC is probably less perturbed
y aging changes, although vertebral compressions can shorten the
runk and “falsely” increase waist measurement. Hip circumference
s affected somewhat by fatness but probably best correlates with
he size of the frame/LBM. Height also correlates with LBM,
ith the noted 20% range of LBM at a given height. Thus, the
atios of WHR and WHtR probably serve as approximate adjust-
ents of WC to individual size. WHtR, an admittedly coarse
easurement, is probably the best available approximation of
verall “fatness,” WF/body weight, for large groups and over broad
anges of age, and was statistically the best model fit (1).
In large populations, almost any reasonable tool, even “eye-
alling,” should provide some approximation of fatness and cor-
elate with fat-related conditions. Behnke (5), who pioneered
uman densitometry, later accommodated to a tape measure and
imple procedures for the practical estimation of body fatness.
ntil improved methods are available, we can best understand
elationships of body composition and future morbidity by appre-
iating the limitations of current anthropometric tools.
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eply
he assessment of clinical usefulness for any measure, and perhaps
articularly for measures of adiposity, relies largely on preference
hen the measures are statistically similar in their associations with
elevant outcomes. While it is true that our study’s results (1) are
ased on analyses of large cohorts, we do not agree that they are
imited in their application to individuals, as suggested by Dr.
reen. In our study, we found that measures of obesity other than
ody mass index (BMI) do not substantially improve statistical
rediction of cardiovascular outcomes. At the same time, we
cknowledged the limitations of BMI, both in misclassifying the
uscular lean and in its deficiency in describing the distribution ofody fat. WThe question then shifts to which measure should be employed
linically. Conveying the risks of obesity to patients in daily clinical
ractice requires, in part, a measure substantiated in standard
efinitions of overweight and obese. While, for a given individual,
hanges in BMI over time will rely on changes in body weight, the
eaning of these changes in weight is often interpreted as progress
oward a healthier goal based on BMI. We do not yet understand
ully how best to target modifications of the waist circumference or
aist-height-ratio, since body fat distribution appears less mallea-
le to change than overall weight. Further study on approaches to
nd benefits of altering body composition and waist circumference
ay clarify these issues.
In our study, we do not advocate a single measure be strictly
mployed in clinical practice. Certainly, for some patients, follow-
ng changes in various anthropometric measures may prove clini-
ally useful in encouraging healthy weight goals. Many patients,
owever, will strive for better health through weight reduction. For
hese individuals, success is defined by a lower BMI, and not by
ther measures.
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eply
rs. Green and Lesser each raise several legitimate and thought-
rovoking issues regarding the article by Gelber et al. (1) and my
ccompanying editorial (2). Their letters highlight several of the
ore important challenges that we face in confronting the obesity
pidemic—first and foremost among these is the very problem of
efining obesity. I concur that there is no single measure of
diposity that is simple to obtain, highly reproducible, widely
vailable, and fully reflective of cardiovascular (or other) risk.
iven this problem, I tried to make a case in the editorial that for
majority of the population, particularly those in the age range
here interventions intended to induce loss of fat are most likely to
e beneficial (younger and middle-age patients), body mass index
BMI) performs nearly as well as waist circumference (or waist/hip
r waist/height). Therefore, until we find a better measure of
atness, I opined that we should continue to use BMI. All that
eing said, I readily agree that BMI has significant limitations as
means to define and quantify obesity.
Dr. Green correctly points out the irresolvable problem of
elating population statistics to the care of individual patients.
hile I agree fully with this point, I believe that the dilemma is
